5-112827951-G-A

Variant names:

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 1P and 1B. PP3BP6

The NM_000038.6(APC):c.1571G>A(p.Gly524Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000124 in 1,613,134 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G524C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)

Exomes 𝑓: 0.000012 ( 0 hom. )

Consequence

APC
NM_000038.6 missense

Scores

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:2

Conservation

PhyloP100: 9.60

Publications

11 publications found

Variant links:

Genes affected

APC (HGNC:583): (APC regulator of WNT signaling pathway) This gene encodes a tumor suppressor protein that acts as an antagonist of the Wnt signaling pathway. It is also involved in other processes including cell migration and adhesion, transcriptional activation, and apoptosis. Defects in this gene cause familial adenomatous polyposis (FAP), an autosomal dominant pre-malignant disease that usually progresses to malignancy. Mutations in the APC gene have been found to occur in most colorectal cancers, where disease-associated mutations tend to be clustered in a small region designated the mutation cluster region (MCR) and result in a truncated protein product. [provided by RefSeq, Jun 2022]

APC Gene-Disease associations (from GenCC):

classic or attenuated familial adenomatous polyposis
Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
desmoid tumor
Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
familial adenomatous polyposis 1
Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
gastric adenocarcinoma and proximal polyposis of the stomach
Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen, Orphanet
sarcoma
Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
APC-related attenuated familial adenomatous polyposis
Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Turcot syndrome with polyposis
Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Cenani-Lenz syndactyly syndrome
Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

APC links:

ENSG00000258864 (HGNC:):

ENSG00000258864 links:

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PP3

MetaRNN computational evidence supports a deleterious effect, 0.812

BP6

Variant 5-112827951-G-A is Benign according to our data. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485. Variant chr5-112827951-G-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 537485.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
APC	NM_000038.6 link	c.1571G>A	p.Gly524Asp	missense_variant	Exon 13 of 16	ENST00000257430.9	NP_000029.2	P25054-1Q4LE70

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
APC	ENST00000257430.9 link	c.1571G>A	p.Gly524Asp	missense_variant	Exon 13 of 16	5	NM_000038.6	ENSP00000257430.4		P25054-1
ENSG00000258864	ENST00000520401.1 link	n.56G>A		non_coding_transcript_exon_variant	Exon 2 of 8	3		ENSP00000454861.1		H3BNH8

Frequencies

GnomAD3 genomes

AF:

0.0000131

AC:

AN:

152178

Hom.:

Cov.:

show subpopulations

Gnomad AFR

AF:

0.00

Gnomad AMI

AF:

0.00

Gnomad AMR

AF:

0.00

Gnomad ASJ

AF:

0.00

Gnomad EAS

AF:

0.00

Gnomad SAS

AF:

0.00

Gnomad FIN

AF:

0.000188

Gnomad MID

AF:

0.00

Gnomad NFE

AF:

0.00

Gnomad OTH

AF:

0.00

GnomAD2 exomes

AF:

0.0000319

AC:

AN:

250896

AF XY:

0.0000221

show subpopulations

Gnomad AFR exome

AF:

0.00

Gnomad AMR exome

AF:

0.0000289

Gnomad ASJ exome

AF:

0.00

Gnomad EAS exome

AF:

0.00

Gnomad FIN exome

AF:

0.0000924

Gnomad NFE exome

AF:

0.0000353

Gnomad OTH exome

AF:

0.000163

GnomAD4 exome

AF:

0.0000123

AC:

AN:

1460956

Hom.:

Cov.:

AF XY:

0.0000138

AC XY:

AN XY:

726810

show subpopulations

African (AFR)

AF:

0.00

AC:

AN:

33456

American (AMR)

AF:

0.0000224

AC:

AN:

44714

Ashkenazi Jewish (ASJ)

AF:

0.0000383

AC:

AN:

26134

East Asian (EAS)

AF:

0.00

AC:

AN:

39680

South Asian (SAS)

AF:

0.00

AC:

AN:

86216

European-Finnish (FIN)

AF:

0.000206

AC:

AN:

53404

Middle Eastern (MID)

AF:

0.00

AC:

AN:

5264

European-Non Finnish (NFE)

AF:

0.00000450

AC:

AN:

1111758

Other (OTH)

AF:

0.00

AC:

AN:

60330

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.492

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Exome Het

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

GnomAD4 genome

AF:

0.0000131

AC:

AN:

152178

Hom.:

Cov.:

AF XY:

0.0000269

AC XY:

AN XY:

74356

show subpopulations

African (AFR)

AF:

0.00

AC:

AN:

41436

American (AMR)

AF:

0.00

AC:

AN:

15270

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

3470

East Asian (EAS)

AF:

0.00

AC:

AN:

5202

South Asian (SAS)

AF:

0.00

AC:

AN:

4822

European-Finnish (FIN)

AF:

0.000188

AC:

AN:

10616

Middle Eastern (MID)

AF:

0.00

AC:

AN:

316

European-Non Finnish (NFE)

AF:

0.00

AC:

AN:

68042

Other (OTH)

AF:

0.00

AC:

AN:

2092

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.450

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Alfa

AF:

0.0000635

Hom.:

Bravo

AF:

0.00000378

ExAC

AF:

0.0000412

AC:

EpiCase

AF:

0.00

EpiControl

AF:

0.0000593

ClinVar

Significance: Conflicting classifications of pathogenicity

Submissions summary: Uncertain:3Benign:2

Revision: criteria provided, conflicting classifications

LINK: link

Submissions by phenotype

Familial adenomatous polyposis 1

Uncertain:2

Mar 06, 2024

Baylor Genetics

Significance:Uncertain significance

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Jan 23, 2025

Labcorp Genetics (formerly Invitae), Labcorp

Significance:Uncertain significance

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 524 of the APC protein (p.Gly524Asp). This variant is present in population databases (rs587782868, gnomAD 0.01%). This missense change has been observed in individual(s) with cancer (PMID: 35430768). ClinVar contains an entry for this variant (Variation ID: 537485). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt APC protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Hereditary cancer-predisposing syndrome

Uncertain:1Benign:1

Nov 14, 2024

Ambry Genetics

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Nov 29, 2021

Sema4, Sema4

Significance:Uncertain significance

Review Status:criteria provided, single submitter

Collection Method:curation

- -

not specified

Benign:1

Mar 04, 2025

Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

AlphaMissense

Pathogenic

0.60

BayesDel_addAF

Pathogenic

0.24

BayesDel_noAF

Pathogenic

0.22

CADD

Uncertain

(source)

DANN

Uncertain

1.0

DEOGEN2

Uncertain

0.53

.;D;D;T;T

Eigen

Uncertain

0.58

Eigen_PC

Uncertain

0.66

FATHMM_MKL

Pathogenic

0.99

LIST_S2

Uncertain

0.93

D;.;D;D;D

M_CAP

Benign

0.067

MetaRNN

Pathogenic

0.81

D;D;D;D;D

MetaSVM

Uncertain

-0.047

MutationAssessor

Benign

1.2

.;L;L;.;.

PhyloP100

9.6

PrimateAI

Pathogenic

0.87

PROVEAN

Pathogenic

-5.1

D;D;D;D;.

REVEL

Pathogenic

0.81

Sift

Benign

0.091

T;T;T;T;.

Sift4G

Benign

0.062

T;D;D;T;T

Polyphen

0.90

.;P;P;.;.

Vest4

0.91, 0.95

MVP

0.93

ClinPred

0.75

GERP RS

5.4

Varity_R

0.89

gMVP

0.75

Mutation Taster

=25/75

disease causing

(source)

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.0

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

Publications

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

Age Distribution

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

Other links and lift over